Kaloba

Pelargonium sidoides, the active ingredient in Kaloba, is a herbal medicine presented as a liquid extract for oral use. It is traditionally employed to support the respiratory system during acute bronchitis and related upper‑respiratory infections in adults and children, and may help alleviate cough and congestion.

GNH USA supplies Kaloba as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions. We maintain rigorous testing and documentation to meet EU and global standards.

Kaloba, containing Pelargonium sidoides extract, is used primarily for conditions affecting the upper respiratory tract. - Acute bronchitis: may shorten the course of cough, reduce sputum production and improve overall respiratory comfort in both adults and children. - Common cold: may alleviate cough, nasal congestion, sore throat and general malaise associated with viral upper‑respiratory infections. - Sinusitis: may facilitate nasal drainage, lessen facial pressure and support recovery from acute sinus inflammation.

Kaloba may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort or diarrhoea. - Altered taste: bitter or metallic sensation in the mouth. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Skin irritation: mild rash or itching at the site of contact. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with breathing difficulty, swelling or hives. - Liver enzyme elevation: signs of hepatic stress such as jaundice. - Stevens‑Johnson syndrome: rare severe skin blistering. - Hemorrhagic events: increased bleeding tendency in patients on anticoagulants. - Hypotension: marked drop in blood pressure causing faintness. - Seizures: rare neurologic events.

When considering Kaloba, several precautionary measures should be observed to ensure safe use. - Pregnancy: avoid use unless clearly indicated by a healthcare professional. - Breastfeeding: discontinue if infant shows signs of intolerance. - Children under 2 years: not recommended due to limited safety data. - Immunocompromised patients: use with caution as immune modulation may be unpredictable. - Concomitant herbal products: assess for overlapping ingredients to prevent additive effects. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Kaloba can interact with other medicines; awareness of potential interactions helps minimise risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Immunosuppressants (e.g., cyclosporine): possible reduction of immunosuppressive efficacy. - Monoamine oxidase inhibitors: risk of hypertensive reactions.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: potential for enhanced hypoglycaemia. - Antihypertensive drugs: additive blood‑pressure‑lowering effect. - CYP450 substrates: may alter metabolism of certain pharmaceuticals.